These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 8467484)

  • 1. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis.
    Murakami H; Sanderson ND; Nagy P; Marino PA; Merlino G; Thorgeirsson SS
    Cancer Res; 1993 Apr; 53(8):1719-23. PubMed ID: 8467484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic mouse models in carcinogenesis: interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis.
    Thorgeirsson SS; Santoni-Rugiu E
    Br J Clin Pharmacol; 1996 Jul; 42(1):43-52. PubMed ID: 8807143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
    Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis.
    Thorgeirsson SS; Santoni-Rugiu E
    Mutat Res; 1997 May; 376(1-2):221-34. PubMed ID: 9202759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic tumor induction in c-myc mono-transgenic and TGF-alpha/c-myc double-transgenic mice.
    Thorgeirsson SS; Santoni-Rugiu E; Davis CD; Snyderwine EG
    Arch Toxicol Suppl; 1997; 19():359-66. PubMed ID: 9079223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
    Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor alpha transgenes.
    Sargent LM; Sanderson ND; Thorgeirsson SS
    Cancer Res; 1996 May; 56(9):2137-42. PubMed ID: 8616862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
    Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
    Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and genetic analysis of liver oncogenesis in transforming growth factor alpha transgenic mice.
    Takagi H; Sharp R; Hammermeister C; Goodrow T; Bradley MO; Fausto N; Merlino G
    Cancer Res; 1992 Oct; 52(19):5171-7. PubMed ID: 1394122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced growth capacity of hepatocytes from c-myc and c-myc/TGF-alpha transgenic mice in primary culture.
    Kao CY; Factor VM; Thorgeirsson SS
    Biochem Biophys Res Commun; 1996 May; 222(1):64-70. PubMed ID: 8630075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer.
    Calvisi DF; Thorgeirsson SS
    Toxicol Pathol; 2005; 33(1):181-4. PubMed ID: 15805070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
    Calvisi DF; Factor VM; Loi R; Thorgeirsson SS
    Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of C-myc and transforming growth factor alfa in the liver promotes early replicative senescence and diminishes regenerative capacity after partial hepatectomy in transgenic mice.
    Factor VM; Jensen MR; Thorgeirsson SS
    Hepatology; 1997 Dec; 26(6):1434-43. PubMed ID: 9397983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression and regulation of hepatic epidermal growth factor receptor in a c-myc transgenic mouse model.
    Woitach JT; Conner EA; Wirth PJ; Thorgeirsson SS
    J Cell Biochem; 1997 Mar; 64(4):651-60. PubMed ID: 9093914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
    Vail ME; Pierce RH; Fausto N
    Cancer Res; 2001 Jan; 61(2):594-601. PubMed ID: 11212255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.
    Liu P; Terradillos O; Renard CA; Feldmann G; Buendia MA; Bernuau D
    Hepatology; 1997 Apr; 25(4):874-83. PubMed ID: 9096591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis.
    Amundadottir LT; Nass SJ; Berchem GJ; Johnson MD; Dickson RB
    Oncogene; 1996 Aug; 13(4):757-65. PubMed ID: 8761297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
    Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
    Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.